Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical gabapentin ointment for neuropathic pain in cancer
IRCT20241207063969N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin in Neuralgia and cancer pain, sponsored by Sabzevar University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
gabapentin
03
Conditions
Neuralgiacancer pain
Beyond the preview
Go deeper on IRCT20241207063969N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241207063969N1.